Evangelos Gragoudas

About Evangelos Gragoudas

Evangelos Gragoudas

Director, Retina Services, Massachusetts Eye and Ear, Boston, Massachusetts

A world authority on the diagnosis and management of intraocular tumors, Evangelos Gragoudas pioneered the use of proton beam irradiation therapy in the treatment of uveal melanoma. Along with Joan Miller and Anthony Adamis, Gragoudas was one of the first to describe the role of VEGF in pathologic retinal neovascularization. With a long-standing interest in retinal disorders, Gragoudas helped identify vascular-targeting therapies for neovascular diseases of the eye, and he was instrumental in developing photodynamic therapy using verteporfin, which became the first FDA-approved treatment for AMD.